Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04452279 · ClinicalTrials.gov registry record · NA
Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification
A NA study, sponsored by Vance Thompson Vision.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT04452279 is a NA study that has completed, run by Vance Thompson Vision. The registered enrollment target is 47 participants.
The verdict
NCT04452279, a NA study, has completed, sponsored by Vance Thompson Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This prospective interventional single-arm trial evaluates measures changes in ocular surface disease parameters in eyes with mild to moderate open-angle glaucoma (OAG) on 1-4 glaucoma medications who undergo phacoemulsification and trabecular micro-bypass stent(s) implantation (iStent or iStent inject).
Interventions
- DEVICE iStent or iStent inject implantation with concomitant cataract surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2019-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04452279
The ClinicalTrials.gov registry entry for NCT04452279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iStent or iStent inject implantation with concomitant cataract surgery is the first listed.
NCT04452279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04452279 about?
NCT04452279 is a clinical study titled "Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification". This prospective interventional single-arm trial evaluates measures changes in ocular surface disease parameters in eyes with mild to moderate open-angle glaucoma (OAG) on 1-4 glaucoma medications who undergo phacoemulsification and trabecular micro-bypass stent(s) implantation (iStent or iStent inj...
What is the current status of trial NCT04452279?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2018-05-01. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT04452279?
The interventions under investigation include: iStent or iStent inject implantation with concomitant cataract surgery (DEVICE).
Who is sponsoring clinical trial NCT04452279?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.